Advertisement
Research Article Free access | 10.1172/JCI107960
Find articles by Richardson, C. in: JCI | PubMed | Google Scholar
Find articles by Bailey, B. in: JCI | PubMed | Google Scholar
Find articles by Walsh, J. in: JCI | PubMed | Google Scholar
Find articles by Fordtran, J. in: JCI | PubMed | Google Scholar
Published March 1, 1975 - More info
The purpose of the present series of experiments was to measure and compare the effects of an anticholinergic drug (isopropamide) and an antagonist of the histamine H2 receptor (metiamide) on food-stimulated acid secretion. Patients with duodenal ulcers were stimulated by a steak meal, and acid secretion was measured by in vivo intragastric titration. The largest dose of isopropamide that can be taken clinically without producing intolerable side effects (maximum tolerated dose) suppressed food-stimulated acid secretion by 35%. By contrast, metiamide in a 400-mg dose produced no side effects and almost completely abolished food-stimulated acid secretion. A dose-response curve revealed that a 50-mg dose of metiamide was required to suppress food-stimulated acid secretion by 50%. Further studies showed that metiamide and isopropamide are additive in suppressing food-stimulated acid secretion, and that metiamide has no effect on serum gastrin concentration or on gastric emptying.
Images.